SCHEMBL10093054

SCHEMBL10093054

CNC(=O)c1ccc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 3/20 0.69
MEN1 O00255 7/20 0.68
KMT2A Q03164 7/20 0.68
CYP2C9 P11712 2/20 0.68
CYP2C19 P33261 2/20 0.68
PSMD14 O00487 2/20 0.68
POLB P06746 2/20 0.68
MAPT P10636 2/20 0.68
CACNA1B Q00975 2/20 0.68
APBA1 Q02410 2/20 0.68
FGB P02675 1/20 0.68
PLEC Q15149 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
UQCRB P14927 2/20 0.64
CA12 O43570 1/20 0.60
CA9 Q16790 1/20 0.60
HDAC1 Q13547 3/20 0.55
HDAC3 O15379 3/20 0.55
HDAC11 Q96DB2 3/20 0.55
HDAC8 Q9BY41 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15948134 0.91 MEN1 (0.69) GPR55MEN1KMT2ACYP2C9CYP2C19
SCHEMBL5047573 0.87 MEN1 (0.70) GPR55MEN1KMT2ACYP2C9CYP2C19
SCHEMBL5048564 0.85 UQCRB (0.71) GPR55MEN1KMT2ACYP2C9CYP2C19
SCHEMBL5943960 0.82 MEN1 (0.66) GPR55MEN1KMT2ACYP2C9CYP2C19
SCHEMBL13454592 0.82 GPR55 (1.00) GPR55MEN1KMT2ACYP2C9CYP2C19
SCHEMBL2026287 0.81 NPC1 (0.67) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL16492508 0.81 CA12 (0.79) MEN1KMT2ACYP2C9CYP2C19PSMD14
SCHEMBL16492507 0.81 CA12 (0.79) MEN1KMT2ACYP2C9CYP2C19PSMD14
Hydrochloric Acid SCHEMBL16600494 0.79 NPC1 (0.64) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL812677 0.79 KMT2A (0.77) GPR55MEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
WO-2010032010-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA GPR55 2136/4885MEN1 4044/4885KMT2A 562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.